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Abstract
Background: This paper reports the methods and findings from a systematic review of economic evaluations
conducted in the community aged care sector between 2000 and 2016.
Methods: Online databases searched were PubMed, Medline, Scopus, and web of science, CINAHL and
informit. Studies were included if they 1) were full economic evaluations that compared both the costs
and outcomes of two or more interventions 2) in study population of people aged 65 years and over
3) dependent older people living in the community 4) alternatives being compared were care models or
service delivery interventions in the community aged care sector (a group of programs that have been
established as a support system to allow older people to remain living in their own homes for as long as
possible, as an alternative to institutional or residential care) and 5) published in the English language
between 2000 and November 2016.
Results: Eleven studies reporting upon economic evaluations of service delivery interventions in community
aged care were identified; the majority of which were undertaken in Europe. Critical appraisal of the identified studies
highlighted the methodological rigour in these evaluations.
Conclusion: This systematic review highlights the paucity of economic evaluation studies conducted to date in the
community aged care sector. The findings highlight the importance of cost utility analysis methodology as it allows for
a uniform outcome measure, that facilitates the comparison of different interventions. In addition, multi-attribute utility
measures that represent those quality of life domains that are most important to older people should be used and
attention must be paid to the inclusion of informal care costs and outcomes as this is a key resource in community
aged care service delivery.
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Background
The World Health Organisation (WHO) has defined
older people as persons who are 65 years or older [1]
while the United Nations (UN) has classified persons
over 60 years of age as older people [2]. By 2050, over
2 billion (22%) of the world’s population will be com-
prised of people aged over 60 years of age and of
these, 402 million individuals will be over 80 years.
Increased aging is associated with increases in de-
pendency and frailty which creates additional de-
mands upon health and aged care services [3]. Older
age in Australia is defined as in the majority of devel-
oped countries as the retirement age or eligibility age
for pension funds of 65+ years. Increased demand for
aged care services coupled with scarce and con-
strained resources in this sector requires a review of
existing policies and new approaches in the provision
of aged care to ensure the efficient allocation of
scarce resources i.e. in a manner that makes society
better off rather than worse off [4, 5].
Aged care services in most developed countries are
provided as government subsidies for older people to
continue living at home, as community aged care ser-
vices or in institutional care facilities or nursing homes
as residential aged care services. Older people can con-
tinue living in the community with support for activities
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of daily living and or instrumental activities of daily
living while those who are highly dependent and in
need of intensive care to support their activities of
daily living tend to live in institutions also referred to
as residential aged care facilities or care homes or
nursing homes [6–8]. Aged care services are provided
under different jurisdiction internationally such as so-
cial care services in the UK [9], long-term care ser-
vices in the USA [10] and most European countries
[11]. Community aged care services are also referred
to as home care services, home-based care, care at
home or home and community-based services [12].
Policy reforms in community aged care service
provision internationally led to the introduction of
consumer directed models of care which aim to im-
prove older people’s involvement in decision making
with regard to the care that they receive [12–14].
However little evidence is currently available to assess
the costs and outcomes associated with these policy
reforms or to determine the cost effectiveness of
models of care in the aged care sector [15, 16].
In contrast to the wide proliferation of economic
evaluations reported upon in the health care sector,
a paucity of economic evaluations have been con-
ducted in community aged care [17]. Economic
evaluation is defined as the comparative assessment
of the cost and benefits of alternative interventions,
also referred to as the comparators [18]. There are
five main types of economic evaluation: cost mini-
misation analysis, cost effectiveness analysis, cost
utility analysis, cost benefit analysis and cost conse-
quence analysis [18]. The key feature that distin-
guishes the different types of economic evaluation is
the unit for measuring the benefits of interventions
in community aged care. Cost effectiveness analysis
focuses upon a single measure of outcome, which is
typically measured in natural units and is specific to
the research question being addressed. Cost utility
analysis is more generally focused on quantifying the
quality of life benefits that older people may obtain
from new innovations in aged care with the main
measure of outcome being quality adjusted life years
(QALYs) [18, 19].
The viewpoint or perspective of an economic evalu-
ation is important as it determines the range of in-
puts/costs and outputs/outcomes to be considered in
the economic evaluation. The societal perspective is
the broadest perspective and is often advocated for
use when evaluating publicly funded programs, where
all costs and benefits to society as a whole irrespect-
ive of who incurs or receives them are considered
[18, 20]. Costs are categorised according to where
they are incurred e.g. community aged care, residen-
tial aged care, health care sector, client/family costs
(the private costs incurred by the client and their
family in receiving care, productivity losses as a result
of the provision of informal care) [18].
The main objectives of this systematic review were
to i) capture the available evidence relating to the
application of economic evaluation in the community
aged care sector and ii) provide a critical appraisal of
previous full economic evaluation studies that com-
pared both the costs and outcomes of two or more
interventions for dependent older people in commu-
nity aged care and published in the English language
(where dependency was defined as needing some as-
sistance to perform activities of daily living through
the receipt of informal care and/or community aged
care services) iii) examining to what extent informal
care was included and the methods used to value in-
formal care e.g. productivity losses. The review fo-
cussed only on full economic evaluations because
these are preferred to partial evaluations by decision
making bodies internationally including the Medical
Services Advisory Committee (MSAC) in Australia
and the National Institute for Health and Care Excel-
lence (NICE) in the UK [21, 22].
Methods
Search strategy and selection criteria
Database: PubMed, Medline, Scopus, CINAHL, infor-
mit, and Web of Science
Search terms:Three key concepts were considered
and incorporated
i. the population was defined by subject headings
such as aged; aged, frail and keywords such as
elder or old age or older person or people or
adult
ii. economic evaluation methodology was defined by
headings including economics; quality-adjusted
life years; costs and cost analysis and keywords
economic analysis or evaluation or model, cost
effectiveness or cost utility or cost benefit, quality
adjusted life years or QALY
iii. community aged care sector was defined by subject
headings such as Homes for the Aged; Independent
Living and keywords such as community care or
home care or community aged care or home living
or community living
The search strategy used in Medline is presented in
Table 1 below.
The study selection process followed the Preferred
Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines for systematic re-
views [23].
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Eligibility criteria
1) studies comparing both costs and outcomes of two or
more interventions undertaken as stand-alone studies or
alongside a clinical trial or other types of study design,
2) study population exclusive to people aged 65 years
and over, 3) dependent older people living in the com-
munity, 4) the alternatives being compared (also referred
to as comparators) were care models or service delivery
interventions in the aged care sector, 5) published in the
English language in peer reviewed journals between
2000 and November 2016.
Studies were excluded if: 1) both costs and outcomes
were not considered and compared e.g. a cost analysis
with no consideration of outcomes, effectiveness studies
with no cost measurement, studies with no comparators,
burden of disease or cost of illness studies 2) study
population was not exclusive to people aged 65 years
and over 3) study population was not based in the com-
munity 4) theory papers, letters, editorials, reviews, the-
ses or dissertations and studies where full texts could
not be obtained.
Two reviewers assessed the articles for eligibility with
the second reviewer independently assessing 20% of the
articles. Overall agreement between reviewers for this
sub-sample was calculated using Cohen’s kappa statistic
[24]. Both reviewers then undertook the quality assess-
ment of included studies and one reviewer undertook
the data extraction and data synthesis.
Data extraction and synthesis
The data in included studies was synthesised narratively
to identify the key methodological principles applied.
Full text articles of included studies were read to obtain
the following categories of information: study design and
type of evaluation, key comparators, perspective/view-
point of the study, the cost categories considered, type
of costing used and the source of costing data, definition
of outcomes and how they were measured, and the key
results and conclusions of the study.
Quality assessment
Economic evaluations that met the eligibility criteria
were critically appraised using the critical appraisal
checklist produced and disseminated by the University
of Glasgow [25] that is based upon the guidelines devel-
oped by Drummond and colleagues [18].
Further assessment was undertaken to investigate the
suitability of instruments applied in measuring quality of
life and QALYs in the CUA studies and to examine the
inclusion of and methods used to value informal care as
a cost or outcome.
Results
Study selection process
Study selection was divided into four main stages (see
Fig. 1):
i. Identification: 10,588 papers were identified from
the database search and an additional 21 from
backward and forward searching the reference lists
of the final studies accepted for the review, 3119
duplicate articles were removed.
ii. Screening: 7490 titles and abstracts were screened
for eligibility; 7354 papers did not meet the
eligibility criteria.
iii. Eligibility: 136 studies full texts articles were read
and further assessed; 85 studies did not compare
care models or service delivery interventions in
community aged care, 24 were cost analysis studies
while the population in 10 studies was not exclusive
to older people and the full text could not be
obtained in six studies.
iv. Included: 11 economic evaluation studies were
included in the qualitative synthesis and narrative
review. Five studies were CEAs, five CUAs and one
CCA. The level of agreement relating to study
exclusion and inclusion between the two reviewers
Table 1 Medline search strategy
# ▲ Searches
1 (community care or home care or community aged care).tw.
2 ((geriatric or elder or ‘older people’) adj2 (home* or apartment*
or residence*)).tw.
3 (((home or community) adj5 (dwelling or based or setting*)) or
(living adj5 (home or community or independent*))).tw.
4 ((community or home* or respite or social or aged) adj5
(care* or welfare* or support*)).tw.
5 Homes for the Aged/ or Health Services for the Aged/ or Social
Welfare/ or Community Health Services/ or Independent Living/
6 or/1–5
7 economics/ or Quality-adjusted life years/
8 exp “costs and cost analysis”/ or cost-benefit analysis/ or “cost of
illness”/ or exp. health care costs/
9 “Value of Life”/ec [Economics]
10 ((economic* adj1 (analys* or evaluat* or model*)) or (cost adj2
(effective* or utilit* or benefit or analysis or minimisation)) or
(“quality adjusted life year*” or qaly)).tw.
11 or/7–10
12 Aged/
13 “aged, 80 and over”/ or frail elderly/
14 (elder* or geriatric* or old age* or ((old* or aged) adj (person or
people* or adult*))).tw.
15 (aged adj (“65” or “70” or “75” or “80” or “85”)).tw.
16 or/12–15
17 6 and 11 and 16
18 limit 17 to (english language and yr = “2000 - Current”)
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was very high/almost perfect with a kappa statistic
of 0.82 [26]
Key findings
The geographical distribution of the studies varied
widely with nearly three quarters (8 studies) undertaken
in Europe, refer to Fig. 2.
The majority (8 studies) of the economic evaluations
were undertaken alongside randomised controlled trials
(RCT). One economic evaluation was undertaken based
on data from a retrospective cohort, and two were
quasi-experimental studies. The sample sizes reported
upon in the identified studies varied greatly from a mini-
mum of 153 to a maximum of over 10,000 participants
(see Table 2).
The most prevalent types of evaluation were cost ef-
fectiveness analysis (5 studies) and cost utility analysis (5
studies) with one study reporting a cost consequence
analysis. No studies were identified that used a cost-
benefit approach. The interventions in 10 studies per-
tained to structures and processes of care/service deliv-
ery. Four studies assessed the value of preventative
home visits compared to usual care where older people
received care from their general practitioner (GP) or
Fig. 1 Study selection process
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social services as and when it was needed [27–30]. Pre-
ventative home visits are designed to monitor the level
of frailty and needs of older people, to preserve func-
tional ability and subsequently delay admission to nurs-
ing homes or residential aged care facilities. One study
assessed the cost effectiveness of re-ablement programs
following hospital stay [31]. Four studies compared inte-
grated multidisciplinary care interventions for frail older
people to usual care where older people seek care from
their GP as and when its needed. Integrated care pro-
grams were interventions that provided services to frail
older people through coordinated multidisciplinary
health teams [32, 33] and social care teams [34, 35].
Two studies compared interventions relating to the or-
ganisation of care; comparing different models for asses-
sing older people’s eligibility for aged care services [36]
and the value of case management in improving older
people’s functional status and health care use [37]. Case
management was an outreach service aimed at improv-
ing older people’s access to and continuity of health care
services through needs assessment, care planning, care
coordination as well as monitoring and evaluation of the
older person’s needs.
The perspectives taken for the economic evaluations
varied with six studies indicating that they had been
undertaken from a societal perspective [27, 28, 32, 34,
35, 37], one study was undertaken from a health system
perspective [30] and one study was undertaken from a
service provider’s perspective [29]. Two studies consid-
ered the public sector (both health and social care) per-
spective [33, 36] whilst no particular perspective was
indicated for the remaining study [31]. The time horizon
for the economic evaluation was predominantly one year
and under (6 studies).
A summary of the included studies is provided in
Table 2.
Application of economic evaluation methodology
Studies applying CUA methodology
As indicated previously, five studies applied a CUA
methodology. One study evaluated the cost effectiveness
of preventive home visits compared to usual care for
community dwelling older people in Germany with time
horizon of 18 months [28], two studies assessed the
value of different processes of care; Sandberg et al. eval-
uated the cost utility of case management programs in
Sweden over 12months [37] while Flood and colleagues
(2005) compared the cost effectiveness of occupational
therapist (OT) led and social worker (SW) led assess-
ment of the needs of older people in the UK over 8
months [36]. All three evaluations were each undertaken
alongside RCTs. The final two studies applying CUA
methodology analysed the cost effectiveness of the Wal-
cheren integrated care model (WICM) alongside a
quasi-experimental study among frail community dwell-
ing older people in the Netherlands at two different time
points; a follow up period of 3 months [35] and 12
months [34].
All studies applied a societal perspective with the con-
sideration of client and family costs including informal
care costs except in one study that applied a public sec-
tor perspective [36]. A micro-costing approach was used
Fig. 2 Geographical distribution of identified studies
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in all studies where client level data was obtained from
records (hospital, nursing homes, social services and
pharmacy) and self-report using resource use
questionnaires.
The primary measure of outcome in all studies, the
QALY, was measured using the EuroQol 5 Dimensions
(EQ-5D-3 L) instrument, a multi-attribute utility meas-
ure of health status. One study [35] assessed quality of
life using both the EQ-5D-3 L and the ICEpop CAPabil-
ity measure for Older people (ICECAP-O), an
older-person-specific measure of capability. Preventative
visits did not improve quality of life and subsequently
the intervention was not cost effective [28], and case
management was found to be cost neutral compared to
usual care [37] while OT led assessment was not cost ef-
fective compared to SW led assessment [36]. The last
two studies highlighted the effect of the outcome meas-
ure on the results of an economic evaluation. There was
no significant differences between WICM and usual care
using the EQ-5D-3 L, a measure of health related quality
of life (HRQoL) at 3 months [35] and even with a longer
time horizon of 12 months [34]. However, there was a
higher probability of cost effectiveness based on capabil-
ity outcomes using the older-person-specific ICECAP-O
[35].
Studies applying CEA methodology
Three studies applied CEA methodology. Two studies
assessed the effectiveness of preventative home visiting
programs to reduce frailty compared to usual care along-
side RCTs in the Netherlands with time horizon of 24
months [27] and 6months [30]. A societal perspective
was adapted in the first study although only health care
and social care costs were included with the exclusion of
client/family costs as well as costs attributable to infor-
mal caring [27]. The second study assessed the Dutch
Geriatric Intervention Program (DGIP), a preventative
home visiting program, over 6 months under a health
system perspective with the inclusion of health care and
social care costs [30]. Both studies applied a
micro-costing approach, using health records and client
self-report for social care utilisation. Self-rated health
(on ten-point Likert type scale ranging from poor to
excellent) was the measure of outcome in the first study
[27] while successful treatment was the measure of out-
come in the second study; successful treatment was
defined by improvement of functional performance in
instrumental activities of daily living (assessed by the
GARS-3) and mental wellbeing (assessed using the
SF-20) [30]. The preventative program assessed by Bou-
man et al. was not found to be cost-effective compared
to usual care while DGIP was cost-effective. Although
these two studies evaluated closely similar interventions
in the same setting (population and country), they
cannot be directly compared because different measures
of outcome were applied.
Another preventative intervention, Advancing Better
Living for Elders (ABLE) was assessed alongside a RCT
in the United States of America (USA) over a two-year
study period [29]. The service provider’s perspective was
taken in this study with only direct /intervention costs
included using a micro-costing approach and life years
saved (LYS) as a measure of outcome. Cost effectiveness
was analysed under two scenarios: using within trial data
and extrapolation to the real world setting where costs
were elevated by 10%; ABLE was cost effective within
the trial and in the real-world setting.
Studies applying CEA and CUA methodology
Two studies applied both CEA and CUA methodology
in assessing the cost effectiveness of integrated care or
multi-disciplinary approaches to the management of
older people at home alongside RCTs. Fairhall et al. eval-
uated a multifactorial interdisciplinary health interven-
tion for older people in Australia over 12 months [33]
while van Leeuwen and colleagues assessed the cost ef-
fectiveness of the Geriatric Care Model (GCM) provid-
ing both health and social care services in the
Netherlands over a 24-month period [32]. The public
sector perspective was applied in Australia with the in-
clusion of health and social care costs. Both
micro-costing and macro-costing approaches were used
to obtain cost data with cost components including
health and social care costs as well as direct intervention
costs. The measure of effectiveness was transition out of
frailty while quality of life was assessed using the
EQ-5D-3 L. The intervention was found to be cost
effective as more people transitioned out of frailty com-
pared to usual care, however, there was no improvement
in QALYs between the two groups and the ICER was
not calculated for the CUA.
Van Leeuwen et al. applied a societal perspective
including health and social care costs as well as the cost
of informal care using a micro-costing approach (data
obtained from hospital and pharmacy records as well as
client cost diaries). Four measures of outcome were con-
sidered in this study; primary outcome was HRQoL
measured by the short-form 12 health questionnaire
(SF-12) and secondary outcomes were QALYs based on
the EQ-5D-3 L and functional limitations in activities of
daily living measured using the Katz basic activity of
daily living scale. There were no differences in all out-
comes between the two alternatives and the GCM was
not found to be cost effective compared to usual care.
Similar to Makai et al. (2014) under CUA, there was
no significant change in HRQoL between the interven-
tion and control group using the EQ-5D-3 L [32, 33] and
the SF-12 [32] in the two studies above, which may
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suggest that HRQoL measures may not be sensitive
when applied in assessing interventions for older people.
Studies applying CCA methodology
To compare the value for money of a home care
re-ablement program against conventional home and
community care (HACC) in Australia, a CCA was con-
ducted based on retrospective data over 5 years [31].
Re-ablement services were comprised of post-discharge
re-ablement (PEP) for older people discharged from hos-
pital back to the community and community based
re-ablement (HIP) offered to community dwelling older
people seeking to improve their levels of function. The
service provider’s perspective was adapted for this study
and only home care service costs were included, with
the utilisation of HACC services as the measure of out-
come. Re-ablement services reduced the need for HACC
services and therefore contain the cost of aged care
services.
Critical appraisal of evaluations
Nine studies were satisfactorily conducted when assessed
according to the critical appraisal criteria (all twelve
questions). One study each were satisfactory in 11 ques-
tions [27] and 10 questions [31].
As the majority of economic evaluations were under-
taken alongside clinical trials, the effectiveness of the
intervention/s under consideration tended to be clearly
established [27, 29, 30, 32, 33, 36–38]. The economic
evaluations based on other study designs demonstrated
effectiveness through a synthesis of evidence collated
from review of literature [31, 34, 35]. Costs and out-
comes were comprehensively identified and measured in
all studies with the exception of one study that was re-
ported as undertaken from a societal perspective but did
not report costs associated with the provision of infor-
mal care [27]. All studies with time horizons beyond one
year discounted both costs and outcomes at the appro-
priate rates based on the country where the study was
undertaken. Notably, the CUA studies were all of high
methodological quality ranking positive on all critical ap-
praisal questions. A summary of the results of the crit-
ical appraisal assessment based on the University of
Glasgow critical appraisal checklist is presented in
Table 3.
Measuring QALYs and HRQoL
In measuring QALYs, all of the studies [28, 34–37]
applied the EQ-5D measure. Two studies using HRQoL
as a measure of effectiveness applied the SF-12 [32] and
SF-20 [30]. The EQ-5D is a multi-attribute utility meas-
ure of quality of life assessing dimensions including mo-
bility, self-care, usual activities, pain/discomfort and
anxiety/depression [39]. The SF-12 and SF-20 are
shorter versions of the generic HRQoL measure SF-36
which assesses eight dimensions of quality of life using
36 questions [40]. The SF-12 contains 12 questions
assessing the original eight dimensions including phys-
ical functioning, role-physical, bodily pain, general
health, vitality, social functioning, role-emotional and
mental health [41] while the SF-20 has 20 questions
assessing physical functioning, role functioning, bodily
pain, current health perspective, social functioning and
mental health [42].
Informal care
At least 30% of participants in all included studies re-
ported themselves as having an informal carer but only
5 studies incorporated the cost of informal care. This
could be attributed to the narrow perspectives applied in
some studies, for example although 75% of participants
in one study [30] reported themselves as having an infor-
mal carer, the cost of informal care was not considered
because the study was conducted under a health sector
perspective. Five of the six studies conducted under a
societal perspective included the cost of informal care
[28, 32, 34, 37, 43] but none considered the effect of the
caring role on carer’s quality of life or informal care on
the outcomes side of the equation. Informal care was
measured through patient recall [28, 37] or resource use
questionnaires completed by the client or the informal
carer [32, 34, 43] and none reported whether informal
care was provided at the same time as other activities
such as leisure activities or joint production. It was val-
ued using the opportunity cost method using the average
wage rate [37] or the replacement cost method using the
wage of a paid carer [28] but the method of valuation
not mentioned in the remaining three studies. Informal
care was a key cost driver in two studies; making the
intervention costlier through increased use [32] and less
costly through reduced use [37]. Sandberg et al., 2005
found no significant differences in costs or quality of life
between the intervention and usual care but the need
for informal care declined in the intervention group
[37].
Discussion
This systematic review has highlighted the paucity of
economic evaluation studies conducted in the commu-
nity aged care sector. The most prevalent types of eco-
nomic evaluation methodologies applied were cost
effectiveness analysis and cost utility analysis.
Whilst a study focusing upon CCA was included in
this review, CCA does not aggregate costs and outcomes
to give an indication of the incremental cost effective-
ness associated with the competing alternatives [18, 44].
It has been suggested however, that this type of analysis
may allow the decision maker more flexibility to select
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those components of costs and outcomes that may be
relevant to their decision and compute a cost effective-
ness ratio if desired [44].
As observed in some of the studies, measurement of
outcomes in natural units is a limitation of CEA as there
is no standard measure of outcome and this affects the
comparability of results between studies [30, 33]. In con-
trast, CUA facilitates direct comparisons between com-
peting interventions most often through the calculation
of QALYs, a generic measure of outcome. Cost utility
analysis is recommended as the preferred approach for
the economic evaluation of interventions in aged care
and has also been highlighted as a useful framework for
the conduct of economic evaluations by key funding
bodies internationally [45–48]. A key issue for the con-
duct of CUA in the community aged care sector is the
identification of appropriate instruments that capture
the breadth of quality of life as defined by older people
[33, 35, 36, 49]. Whilst widely validated measures such
as the EQ-5D were applied in the studies identified in
this review, HRQoL measures primarily focus on health
and physical functioning and do not specifically address
dimensions of quality of life that are most important to
older people and may not be sensitive to quality of life
improvements in this population [19, 32, 35, 50]. Several
commentators have argued that to comprehensively
reflect quality of life benefits of interventions to older
people, one requires an instrument that not only mea-
sures health and physical functioning but includes
dimensions that are important to older people in receipt
of aged care particularly psychosocial functioning, the
ability to be independent, control over daily lives and in-
volvement in decision making, and also defines health as
a resource to help them achieve their goals and facilitate
social and physical participation [50–53]. Two reviews of
instruments suitable for use in economic evaluations
involving older people have highlighted the potential
benefits of the use of preference based instruments such
as the ICECAP-O and the Adult Social Care Outcomes
Toolkit (ASCOT) which both have a focus on wider
quality of life attributes beyond health status [43, 54].
Depending on the intervention under review, such in-
struments may be applied in combination with HRQoL
instruments [55–57].
Table 3 Results of the critical appraisal
Study reference Is the EE
likely to be
usable
How were costs and
outcomes assessed and
compared
Will the results
help in
purchasing for
local people
Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12
Cost-Utility Analysis Of Preventive Home Visits program for Older
Adults in Germany [38]
Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes
Cost utility analysis of case management for frail older people:
effects of a randomised controlled trial [37]
Yes Yes Yes Yes Yes Yes N/
A*
No Yes Yes Yes Yes
Occupational therapy compared with social work assessment for
older people. An economic evaluation alongside the CAMELOT
randomised controlled trial [36]
Yes Yes Yes Yes Yes Yes N/
A*
Yes Yes Yes Yes Yes
Cost-effectiveness of integrated care in frail elderly using the ICECAP-O
and EQ-5D: does choice of instrument matter? [35]
Yes Yes Yes Yes Yes Yes N/
A*
Yes Yes Yes Yes Yes
Cost effectiveness of the Walcheren Integrated Care Model intervention
for community dwelling frail elderly [34]
Yes Yes Yes Yes Yes Yes N/
A*
Yes Yes Yes Yes Yes
Effects on health care use and associated cost of a home visiting program
for older people with poor health status: A randomized clinical trial in the
Netherlands [27]
Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes
Cost effectiveness of a multi-disciplinary intervention model for community-
dwelling frail older people [30]
Yes Yes Yes Yes Yes Yes N/
A*
Yes Yes Yes Yes Yes
Economic Evaluation of a Multifactorial, Interdisciplinary Intervention
Versus Usual Care to Reduce Frailty in Frail Older People [33]
Yes Yes Yes Yes Yes Yes N/
A*
Yes Yes Yes Yes Yes
Cost effectiveness of a chronic care model for frail older adults in primary care:
economic evaluation alongside a stepped-wedge cluster randomised trial [32]
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Cost effectiveness of a home-based intervention that helps functionally
vulnerable older adults age in place at home [29]
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Evidence for the long-term cost effectiveness of home care re-ablement
programs [31]
Yes Yes Yes Yes C Yes N/
A*
N/
A*
C Yes Yes Yes
Q1: Well-defined question; Q2: Comprehensive description of alternative; Q3: Evidence of effectiveness; Q4: Important/ relevant outcomes and costs identified; Q5:
Outcomes and costs measured accurately in appropriate units; Q6: Outcomes and costs valued credibly; Q7: Discounting; Q8: Incremental analysis of the
outcomes and costs; Q9: Sensitivity analysis; Q10: Discussion of the results include issues that are of concern to purchasers; Q11: Conclusion justified by the
evidence presented; Q12: Results applicable to local population; *N/A is considered as an answered question
Bulamu et al. BMC Health Services Research          (2018) 18:967 Page 10 of 13
Some commentators have also argued that the QALY
metric may not be a suitable measure for older people as
its calculation is based on a combination of quality of
life and length of life, which by default discriminates
against older people with a shorter life expectancy
[52, 58, 59]. Yet the derivation of value sets for most
instruments with the QALY scale has been predomin-
antly based on populations with younger age groups
(18–64 years) and less representation of older people
(over 65 years) [5, 60].
The Second Panel on Cost-Effectiveness in Health and
Medicine recommends that results of economic evalua-
tions should be reported from a societal perspective as a
reference case with the inclusion of informal care costs
[61]. A review of the inclusion of informal care in
applied economic evaluation found that only a small
proportion of studies formally included informal care
[62]. Our findings were consistent with this review. Al-
though most study participants (at least 30% in all stud-
ies) reported themselves as having an informal carer,
only five studies considered the cost of informal care
and none formally considered the impacts upon carers.
The time spent providing informal care (such as per-
sonal care and household tasks) is a resource that is used
up as a result of caring, and so carers should arguably be
considered as a cost in economic evaluation. The carer’s
quality of life, however, may also be affected by a per-
son’s condition, and so outcomes for carers may also be
relevant in an economic evaluation. Within the CUA
framework, a new instrument the Carer Experience
Scale (CES) which has been specifically designed for
carers to measure and value the impact upon caring as-
sociated the introduction of new interventions may be
particularly helpful. However, it has been argued that in-
corporating both carer costs and outcomes in the cost
effectiveness ratio (CER) may result in double counting
as carers may have considered their quality of life when
valuing their time [63]. Other commentators suggest
that carer effects may be accounted for on the cost side
of the equation if monetary methods of valuing benefits
are used and on the effects side when non-monetary
methods of valuing benefits are applied [64, 65]. Another
possible option is to move beyond assessment of quality
of life within CUA and incorporate the wider impacts of
an intervention upon the caring role in monetary terms
within the framework of cost benefit analysis [66].
Overall, most of the interventions included in this
review were not found to be cost effective, which was
largely attributed to the short time horizons applied
in these studies. A longer time horizon is recom-
mended for service delivery interventions that involve
the integration of various sectors and building of net-
works in service delivery such as in the community
aged care sector to permit the intervention to go
beyond the teething problems and adjustment phases
to then observe the benefits attributed to the inter-
vention [34, 37, 67, 68].
Strengths of this review include the systematic ap-
proach to data collection using a comprehensive search
strategy in multi-disciplinary health databases and the
geographical variation in the studies included that
allowed for a snapshot of the evaluation of aged care ser-
vices internationally. However, it was also a challenge as
the aged care system and definition of services varies
from one country to another and affects the comparabil-
ity of the different studies. The review was also limited
to empirical research published in the English language
(model-based studies and grey literature were excluded)
and full-text that could be accessed through the univer-
sity library system.
Conclusion
In contrast to the high prevalence of economic evalua-
tions conducted in the health care sector this systematic
review has identified that relatively few economic evalu-
ations have been conducted to date in the community
aged care sector. The findings highlight the importance
of cost utility analysis methodology as it allows for a uni-
form outcome measure, that facilitates the comparison
of different interventions. Within cost utility analysis,
multi-attribute utility measures that represent those
quality of life domains that are most important to older
people should be used and attention must be paid to the
inclusion of informal care costs and outcomes as this is
a key resource in community aged care service delivery.
Future research should be directed towards developing
methods and applications to facilitate the inclusion of
carers effects in the economic evaluation of interven-
tions for the community aged care sector.
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